BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 18941713)

  • 1. Amino acetate functionalized Schiff base organotin(IV) complexes as anticancer drugs: synthesis, structural characterization, and in vitro cytotoxicity studies.
    Baul TS; Basu S; de Vos D; Linden A
    Invest New Drugs; 2009 Oct; 27(5):419-31. PubMed ID: 18941713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, photophysical properties and structures of organotin-Schiff bases utilizing aromatic amino acid from the chiral pool and evaluation of the biological perspective of a triphenyltin compound.
    Basu Baul TS; Kehie P; Duthie A; Guchhait N; Raviprakash N; Mokhamatam RB; Manna SK; Armata N; Scopelliti M; Wang R; Englert U
    J Inorg Biochem; 2017 Mar; 168():76-89. PubMed ID: 28024187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancement towards tin-based anticancer chemotherapeutics: structural modification and computer modeling approach to drug-enzyme interactions.
    Basu Baul TS; Dutta D; de Vos D; Höpfl H; Pooja ; Singh P
    Curr Top Med Chem; 2012; 12(24):2810-26. PubMed ID: 23368104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro comparative assessment with a series of new triphenyltin(IV) 2-/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with anticancer activities: structural modifications, analysis of efficacy and cytotoxicity involving human tumor cell lines.
    Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Duthie A; de Vos D; Verma RP; Englert U
    J Inorg Biochem; 2012 Feb; 107(1):119-28. PubMed ID: 22182574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triphenyltin(IV) 2-[(E)-2-(aryl)-1-diazenyl]benzoates as anticancer drugs: synthesis, structural characterization, in vitro cytotoxicity and study of its influence towards the mechanistic role of some key enzymes.
    Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Singh P; Verma P; de Vos D
    Invest New Drugs; 2010 Oct; 28(5):587-99. PubMed ID: 19641849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of the interaction of novel tributyltin(IV) 2/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with an improved cytotoxic profile: synthesis, structure, biological efficacy and QSAR studies.
    Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Pellerito C; Singh P; Verma P; Duthie A; de Vos D; Verma RP; Englert U
    J Inorg Biochem; 2010 Sep; 104(9):950-66. PubMed ID: 20553814
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Yusof ENM; Latif MAM; Tahir MIM; Sakoff JA; Simone MI; Page AJ; Veerakumarasivam A; Tiekink ERT; Ravoof TBSA
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organotin(IV) complexes derived from Schiff base N'-[(1E)-(2-hydroxy-3-methoxyphenyl)methylidene]pyridine-4-carbohydrazone: synthesis, in vitro cytotoxicities and DNA/BSA interaction.
    Hong M; Geng H; Niu M; Wang F; Li D; Liu J; Yin H
    Eur J Med Chem; 2014 Oct; 86():550-61. PubMed ID: 25216377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, structural characterization and in vitro cytotoxicity of organotin(IV) derivatives of heterocyclic thioamides, 2-mercaptobenzothiazole, 5-chloro-2-mercaptobenzothiazole, 3-methyl-2-mercaptobenzothiazole and 2-mercaptonicotinic acid.
    Xanthopoulou MN; Hadjikakou SK; Hadjiliadis N; Schürmann M; Jurkschat K; Michaelides A; Skoulika S; Bakas T; Binolis J; Karkabounas S; Charalabopoulos K
    J Inorg Biochem; 2003 Aug; 96(2-3):425-34. PubMed ID: 12888279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The triphenyltin(VI) complexes of NSAIDs and derivatives. Synthesis, crystal structure and antiproliferative activity. Potent anticancer agents.
    Dokorou V; Primikiri A; Kovala-Demertzi D
    J Inorg Biochem; 2011 Feb; 105(2):195-201. PubMed ID: 21194618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organometallic complexes with biological molecules. XVIII. Alkyltin(IV) cephalexinate complexes: synthesis, solid state and solution phase investigations.
    Di Stefano R; Scopelliti M; Pellerito C; Casella G; Fiore T; Stocco GC; Vitturi R; Colomba M; Ronconi L; Sciacca ID; Pellerito L
    J Inorg Biochem; 2004 Mar; 98(3):534-46. PubMed ID: 14987855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentially bioactive organotin(IV) compounds: synthesis, characterization, in vitro bioactivities and interaction with SS-DNA.
    Sirajuddin M; Ali S; McKee V; Sohail M; Pasha H
    Eur J Med Chem; 2014 Sep; 84():343-63. PubMed ID: 25036793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diorganotin(IV) N-acetyl-L-cysteinate complexes: synthesis, solid state, solution phase, DFT and biological investigations.
    Pellerito L; Prinzivalli C; Casella G; Fiore T; Pellerito O; Giuliano M; Scopelliti M; Pellerito C
    J Inorg Biochem; 2010 Jul; 104(7):750-8. PubMed ID: 20421134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diorganotin(IV) complexes of dipeptides containing the alpha-aminoisobutyryl residue (Aib): preparation, structural characterization, antibacterial and antiproliferative activities of [(n-Bu)2 Sn(H(-1)L)] (LH=H-Aib-L-Leu-OH, H-Aib-L-Ala-OH).
    Katsoulakou E; Tiliakos M; Papaefstathiou G; Terzis A; Raptopoulou C; Geromichalos G; Papazisis K; Papi R; Pantazaki A; Kyriakidis D; Cordopatis P; Manessi-Zoupa E
    J Inorg Biochem; 2008 Jul; 102(7):1397-405. PubMed ID: 18289688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfonated Schiff base Sn(IV) complexes as potential anticancer agents.
    Hazra S; Paul A; Sharma G; Koch B; da Silva MFCG; Pombeiro AJL
    J Inorg Biochem; 2016 Sep; 162():83-95. PubMed ID: 27338202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological investigations and Petra/Osiris/Molinspiration (POM) analyses of newly synthesized potentially bioactive organotin(IV) carboxylates.
    Tariq M; Sirajuddin M; Ali S; Khalid N; Tahir MN; Khan H; Ansari TM
    J Photochem Photobiol B; 2016 May; 158():174-83. PubMed ID: 26974578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, crystal structures, cytotoxicity and qualitative structure-activity relationship (QSAR) of cis-bis{5-[(E)-2-(aryl)-1-diazenyl]quinolinolato}di-n-butyltin(IV) complexes, (n)Bu2Sn(L)2.
    Basu Baul TS; Mizar A; Chandra AK; Song X; Eng G; Jirásko R; Holcapek M; de Vos D; Linden A
    J Inorg Biochem; 2008 Sep; 102(9):1719-30. PubMed ID: 18571240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization, crystal structures and in vitro antistaphylococcal activity of organotin(IV) derivatives with 5,7-disubstituted-1,2,4-triazolo[1,5-a]pyrimidine.
    Girasolo MA; Canfora L; Sabatino P; Schillaci D; Foresti E; Rubino S; Ruisi G; Stocco G
    J Inorg Biochem; 2012 Jan; 106(1):156-63. PubMed ID: 22119808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-step preparation, structural assignment, and X-ray study of 2,2-di-n-butyl- and 2,2-diphenyl-6-aza-1,3-dioxa-2-stannabenzocyclononen-4-ones derived from amino acids.
    Beltrán HI; Zamudio-Rivera LS; Mancilla T; Santillan R; Farfán N
    Chemistry; 2003 May; 9(10):2291-306. PubMed ID: 12772304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triphenyltin(IV) benzoates with diazenyl/imino scaffold exhibiting remarkable apoptosis mediated by reactive oxygen species.
    Basu Baul TS; Dutta D; Duthie A; Prasad R; Rana NK; Koch B; Tiekink ERT
    J Inorg Biochem; 2017 Aug; 173():79-92. PubMed ID: 28505480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.